Posts by Eric Klawiter, MD, MSc
-
Imaging Technology Advances Multiple Sclerosis Research
Massachusetts General Hospital is developing and testing new imaging techniques to better understand multiple sclerosis (MS) pathology, physical symptoms and cognitive impairment associated with MS.
-
Mass General Neurologists Research Effects of COVID-19 on the Brain
A COVID-19 smell test, a longitudinal study of patients with multiple sclerosis who develop COVID-19 and high-intensity support for the brain health of COVID-19 survivors are among the research projects underway at Massachusetts General Hospital.
-
Ibudilast Slows Progression of Brain Atrophy in Multiple Sclerosis
In the SPRINT-MS phase 2 trial that involved patients with progressive multiple sclerosis, NeuroNEXT investigators found that progression of brain atrophy was significantly slower with the small molecule ibudilast than with placebo.
Biography
Eric Klawiter, MD, MSc is an Assistant Neurologist at Massachusetts General Hospital who specializes in multiple sclerosis (MS) and related diseases. He received his medical training at the Sanford School of Medicine at the University of South Dakota. Following medical school, he completed a medical internship and residency in Neurology at Barnes-Jewish Hospital and Washington University in St. Louis. Dr. Klawiter received fellowship training in neuroimmunology (multiple sclerosis) at Washington University where he was the recipient of a Clinical Research Training Fellowship from the American Academy of Neurology.
Dr. Klawiter's research interests include multiple sclerosis clinical research and developing new imaging techniques to better understand, diagnose and treat multiple sclerosis. He has written numerous publications and book chapters relating to multiple sclerosis and neuromyelitis optica. Additionally, he has participated in multiple clinical trials of multiple sclerosis therapeutic agents.